510(k) K253082

LZI Buprenorphine II Enzyme Immunoassay by Lin-Zhi International, Inc. — Product Code DJG

K253082 is an FDA 510(k) premarket notification submitted by Lin-Zhi International, Inc. for the device "LZI Buprenorphine II Enzyme Immunoassay". The FDA issued a decision of Substantially Equivalent on Jan 16, 2026. The device falls under product code DJG (Enzyme Immunoassay, Opiates), a Class II device regulated under 21 CFR 862.3650. Lin-Zhi International, Inc. has 49 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 16, 2026
Date Received
Sep 23, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Opiates
Device Class
Class II
Regulation Number
862.3650
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Lin-Zhi International, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K253082. Report a data issue: hello@regdatalab.com.